Author

J. Xian

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:statistical model· 1 Research Focus:trajectory inference· 1

Frequent Co-Authors

A. Hobeika· 1 shared A. Nicholls· 1 shared C. A. Rebbeck· 1 shared C. Bai· 1 shared C. Zhou· 1 shared D. Liu· 1 shared E. Rozhkova· 1 shared G. J. Hannon· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Hobeika

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection

X. He, J. Jiang, G. Li, J. Liu, J. Gan, L. Zhou, C. Bai, Q. Zi, X. Mou, S. Zeng, J. Yuan, C. Zhou, Y. Li, G. Zhu, R. Zhao, , W. Li

This study evaluates hybrid immunity against the Omicron variant JN.1 11 months after breakthrough infection, showing heterogeneous responses and increased neutralization following reinfection.

bioRxiv · Mar 2, 2024Immunology

Creating a 'Timeline' of ductal carcinoma in situ to identify processes and biomarkers for progression towards invasive ductal carcinoma

C. A. Rebbeck, J. Xian, S. Bornelov, J. Geradts, A. Hobeika, H. Geiger, J. F. Alvarez, E. Rozhkova, A. Nicholls, N. Robine, H. K. Lyerly, G. J. Hannon

The paper generates a disease progression timeline for DCIS using gene expression data to identify early processes and biomarkers associated with progression to invasive breast cancer.

bioRxiv · Mar 1, 2022Cancer Biology